Descriptive Comparison of Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) plus Pegylated-Interferon α-2a (PEG) Combination in Asians and non-Asians with Chronic Hepatitis B (CHB)

被引：0
|
作者：
Marcellin, Patrick [2 ]
Ahn, Sang Hoon [3 ]
Tak, Won Young [4 ]
Tsang, Owen Tak Yin [8 ]
Hui, Aric Josun [5 ]
Ma, Xiaoli [6 ]
Chuang, Wan-Long [7 ]
Lim, Seng Gee [9 ]
Mehta, Rajiv [10 ]
Martins, Eduardo B. [1 ]
Yee, Leland J. [1 ]
Dinh, Phillip [1 ]
Lin, Lanjia [1 ]
Charuworn, Prista [1 ]
Subramanian, Mani [1 ]
Fung, Scott [11 ]
Elkhashab, Magdy [12 ]
Trinh, Huy N. [13 ]
Chan, Henry Lik-Yuen [14 ]
机构：
[1] Gilead Sci Inc, Foster City, CA 94404 USA
[2] Univ Paris Diderot, Hop Beaujon, Clichy, France
[3] Yonsei Univ, Coll Med, Seoul, South Korea
[4] Kyungpook Natl Univ Hosp, Daegu, South Korea
[5] Alice Ho Miu Ling Nethersole Hosp, Hong Kong, Hong Kong, Peoples R China
[6] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
[7] Kaohsiung Med Univ, Chung Ho Mem Hosp, Kaohsiung, Taiwan
[8] Princess Margaret Hosp, Hong Kong, Hong Kong, Peoples R China
[9] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore
[10] Liver Clin, Surat, India
[11] Toronto Gen Hosp, Toronto, ON, Canada
[12] Toronto Liver Ctr, Toronto, ON, Canada
[13] San Jose Gastroenterol, San Jose, CA USA
[14] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2025
引用
收藏
页码：1196A / 1196A
页数：1
相关论文
共 50 条
  • [1] Tenofovir disoproxil fumarate (TDF) shows similar virologic suppression and safety between Asians and non-Asians with chronic hepatitis B (CHB)
    Pan, C.
    Chan, S.
    Trinh, H. N.
    Yao, A.
    Bae, H.
    Marcellin, P.
    Heathcote, E. J.
    Elsome, A. M.
    Chiang, B.
    Lou, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 102 - 102
  • [2] Tenofovir Disoproxil Fumarate (TDF) Shows Similar Virologic Suppression and Safety Between Asians and Non-Asians With Chronic Hepatitis B (CHB)
    Pan, Calvin
    Chan, Sing
    Trinh, Huy N.
    Yao, Alan
    Bae, Ho
    Marcellin, Patrick
    Heathcote, E. Jenny
    Chiang, Betty
    Lou, Lillian
    GASTROENTEROLOGY, 2011, 140 (05) : S896 - S896
  • [3] Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B
    Calvin Q Pan
    Sing Chan
    Huy Trinh
    Alan Yao
    Ho Bae
    Lillian Lou
    World Journal of Gastroenterology, 2015, (18) : 5524 - 5531
  • [4] Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B
    Pan, Calvin Q.
    Chan, Sing
    Trinh, Huy
    Yao, Alan
    Bae, Ho
    Lou, Lillian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (18) : 5524 - 5531
  • [5] FOUR YEARS EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN ASIANS WITH HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHB), PRELIMINARY ANALYSIS
    Gane, Edward J.
    Lee, Samuel S.
    Heathcote, E. Jenny
    Sievert, William
    Trinh, Huy N.
    Kaita, Kelly D.
    Younossi, Zobair M.
    George, Jacob
    Marcellin, Patrick
    Coombs, Derek H.
    Anderson, Jane
    Mondou, Elsa
    HEPATOLOGY, 2010, 52 (04) : 559A - 559A
  • [6] Safety and efficacy in lamivudine (LAM) experienced chronic hepatitis B (CHB) patients treated for 2 years with tenofovir disoproxil fumarate (TDF)
    Roberts, S. K.
    Gane, E. J.
    Weilert, F.
    Sievert, W.
    George, J.
    Strasser, S. I.
    Kronborg, I.
    Heathcote, E. J.
    Marcellin, P.
    Sorbel, J.
    Rousseau, F.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A299 - A299
  • [7] Comparison of Pegylated Interferon Alfa Therapy in Combination with Tenofovir Alafenamide Fumarate or Tenofovir Disoproxil Fumarate for Treatment of Chronic Hepatitis B Patients
    He, Jingjing
    Guo, Yifei
    Zhang, Yao
    Han, Jiajia
    Chen, Jingwen
    Jia, Yidi
    Ma, Zhenxuan
    Wu, Jingwen
    Zhang, Shenyan
    Li, Fahong
    Mao, Richeng
    Zhang, Jiming
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 3929 - 3941
  • [8] THREE YEARS EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) IN ASIANS WITH HBEAG-POSITIVE AND HBEAG-NEGATIVE CHRONIC HEPATITIS B, PRELIMINARY ANALYSIS
    Lee, Samuel S.
    Heathcote, E. Jenny
    Sievert, William
    Trinh, Huy N.
    Kaita, Kelly D.
    Younossi, Zobair M.
    George, Jacob
    Shiffman, Mitchell L.
    Marcellin, Patrick
    Sorbel, Jeff
    Anderson, Jane
    Mondou, Elsa
    Ouinn, Joe
    Rousseau, Franck
    HEPATOLOGY, 2009, 50 (04) : 538A - 538A
  • [9] HBsAg Loss with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2a (PEG) in Chronic Hepatitis B (CHB): Results of a Global Randomized Controlled Trial
    Marcellin, Patrick
    Ahn, Sang Hoon
    Ma, Xiaoli
    Caruntu, Florin A.
    Tak, Won Young
    Elkashab, Magdy
    Chuang, Wan-Long
    Tabak, Fehmi
    Mehta, Rajiv
    Petersen, Joerg
    Martins, Eduardo B.
    Dinh, Phillip
    Corsa, Amoreena C.
    Charuworn, Prista
    Subramanian, Mani
    McHutchison, John G.
    Buti, Maria
    Gaeta, Giovanni B.
    Papatheodoridis, George V.
    Flisiak, Robert
    Chan, Henry Lik-Yuen
    HEPATOLOGY, 2014, 60 : 294A - 295A
  • [10] Predictors of clinical response: results from a large, randomized controlled study with Tenofovir Disoproxil Fumarate (TDF) plus Peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)
    Strasser, S.
    Chan, H.
    Ahn, S.
    Chuang, W.
    Hui, A.
    Tabak, F.
    Mehta, R.
    Petersen, J.
    Lee, C.
    Ma, X.
    Caruntu, F.
    Tak, W.
    Elkhashab, M.
    Lin, L.
    Dinh, P.
    Martins, E.
    Charuworn, P.
    Mchutchison, J.
    Subramanian, G. M.
    Lim, S.
    Foster, G.
    Fung, S.
    Morano, L.
    Samuel, D.
    Agarwal, K.
    Idilman, R.
    Buti, M.
    Gaeta, G.
    Papatheodoridis, G.
    Flisiak, R.
    Marcellin, P.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 91 - 92
12345